Your Location:
Home >
Browse articles >
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 1, Pages: 95-102(2024)
DOI: 10.13422/j.cnki.syfjx.20232025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 6 )
References
Publication Info
Metrics
239
Views
142
Downloads
8
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway
Mechanisms of Shenmai Injection in Improving Cisplatin Resistance in Non-small Cell Lung Cancer
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
Differential Analysis of Clinical Features and Outcomes Between Syndrome of Combined Phlegm and Stasis and Syndrome of Dampness-heat Internal Accumulation in Hepatic Wilson's Disease
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Related Author
YU Dan
MU Qirui
LI He
LIU Yuetong
HUANG Jingyi
GAO Yuan
DONG Hanyu
WANG Chun
Related Institution
College of Integrated Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine
Key Laboratory of Ministry of Education for Traditional Chinese Medicine(TCM) Viscera-State Theory and Applications, Liaoning University of TCM
First Clinical College, Liaoning University of TCM
School of Basin Medical Sciences,Liaoning University of TCM
Teaching and Experimental Center,Liaoning University of TCM


